The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals
Open accessAbstract
Objectives: Amyloid‐beta (Aβ) and tau pathologies are commonly observed among clinically normal older individuals at postmortem and can now be detected with in vivo neuroimaging. The association and interaction of these proteinopathies with prospective cognitive decline in normal aging and preclinical Alzheimer's disease (AD) remains to be fully elucidated. Methods: One hundred thirty‐seven older individuals (age = 76.3 ± 6.22 years) participating in the Harvard Aging Brain Study underwent Aβ ( 11 C‐Pittsburgh compound B) and tau ( 18 F‐flortaucipir) positron emission tomography (PET) with prospective neuropsychological assessments following PET imaging (mean number of cognitive visits = 2.8 ± 1.1). Tau and Aβ PET measures were assessed in regions of interest (ROIs) as well as vertex‐wise map analyses. Cognitive change was evaluated with Memory and Executive Function composites. Results: Higher levels of Aβ and tau were both associated with greater memory decline, but not with change in executive function. Higher cortical Aβ was associated with higher tau levels in all ROIs, independent of age, and very elevated levels of tau were observed primarily in clinically normal with elevated Aβ. A significant interaction between tau and Aβ was observed in both ROI and map‐level analyses, such that rapid prospective memory decline was observed in participants who had high levels of both pathologies. Interpretation: Our results are consistent with the supposition that both Aβ and tau are necessary for memory decline in the preclinical stages of AD. These findings may be relevant for disambiguating aging and early cognitive manifestations of AD, and to inform secondary prevention trials in preclinical AD. Ann Neurol 2019;00:1–3 ANN NEUROL 2019;85:181–193.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The regional specificity of these findings aligns with evidence that entorhinal cortex is a site of preclinical neuropathological tau deposition that is elevated for APOE4 carriers [37] and predicts cognitive decline [38], and which undergoes accelerated atrophy in preclinical AD [39].”
From Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1×
“Autopsy reports suggest that tau deposition in the entorhinal cortex (EC) is nearly ubiquitous in advanced aging, whereas spread into the surrounding temporal neocortex is less commonly observed among CN older individuals, particularly in the absence of substantial Aβ pathology.(18) It remains unclear whether EC tau a…”
BackgroundPreclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Self-citationFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
PET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
Tau positron emission tomographic imaging in aging and early Alzheimer disease
Johnson, K. A., Schultz, A., Betensky, R. A., Becker, J. A., Sepulcre, J., Rentz, D., Mormino, E., Chhatwal, J., Amariglio, R., Papp, K., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24546 · Cited by 986
Self-citation
Cited by
Sorted by citations
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803
Self-citationSynergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
Biomarkers for neurodegenerative diseases
Hansson, O. (2021) · Nature Medicine · doi:10.1038/s41591-021-01382-x · Cited by 1,159
Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00066-1 · Cited by 1,051
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Self-citationInteraction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease
Zhang, H., Wei, W., Zhao, M., Ma, L., Jiang, X., Pei, H., Cao, Y., & Li, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57078 · Cited by 689
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
Ossenkoppele, R., van der Kant, R., & Hansson, O. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00168-5 · Cited by 557
Ossenkoppele, R., Pichet Binette, A., Groot, C., Smith, R., Strandberg, O., Palmqvist, S., Stomrud, E., Tideman, P., Ohlsson, T., Jögi, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02049-x · Cited by 496
Self-citationOssenkoppele, R., Smith, R., Mattsson-Carlgren, N., Groot, C., Leuzy, A., Strandberg, O., Palmqvist, S., Olsson, T., Jögi, J., Stormrud, E., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.1858 · Cited by 311
Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals
Sperling, R. A., Donohue, M., Raman, R., Sun, C., Yaari, R., Holdridge, K. C., Siemers, E., Johnson, K. A., Aisen, P. S. S., & for the A4 Study Team (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0387 · Cited by 338
Self-citationAmyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
Villegas, S., Roda, A., Serra-Mir, G., Montoliu-Gaya, L., & Tiessler, L. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.332127 · Cited by 306
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease
Rafii, M. S., Sperling, R. A., Donohue, M. C., Zhou, J., Roberts, C., Irizarry, M. C., Dhadda, S., Sethuraman, G., Kramer, L. D., Swanson, C. J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12748 · Cited by 291
Self-citationTherriault, J., Vermeiren, M. R., Servaes, S., Tissot, C., Ashton, N. J., Benedet, A. L., Karikari, T. K., Lantero‐Rodriguez, J., Brum, W. S., Lussier, F. Z., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.4485 · Cited by 278
Jacobs, H. I. L., Becker, J. A., Kwong, K. K., Engels, N., Prokopiou, P. C., Papp, K. V., Properzi, M. J., Hampton, O. L., Uquillas, F. D., Sanchez, J. S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj2511 · Cited by 236
Self-citationJack, C. R., Wiste, H. J., Botha, H., Weigand, S. D., Therneau, T. M., Knopman, D. S., Graff-Radford, J., Jones, D. T., Ferman, T. J., Boeve, B. F., et al. (2019) · Brain · doi:10.1093/brain/awz268 · Cited by 200
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
Betthauser, T. J., Koscik, R. L., Jonaitis, E. M., Allison, S. L., Cody, K. A., Erickson, C. M., Rowley, H. A., Stone, C. K., Mueller, K. D., Clark, L. R., et al. (2019) · Brain · doi:10.1093/brain/awz378 · Cited by 176
Predicting amyloid PET and tau PET stages with plasma biomarkers
Jack, C. R., Wiste, H. J., Algeciras‐Schimnich, A., Figdore, D. J., Schwarz, C. G., Lowe, V. J., Ramanan, V. K., Vemuri, P., Mielke, M. M., Knopman, D. S., et al. (2023) · Brain · doi:10.1093/brain/awad042 · Cited by 154
Multicellular communities are perturbed in the aging human brain and Alzheimer’s disease
Cain, A., Taga, M., McCabe, C., Green, G. S., Hekselman, I., White, C. C., Lee, D. I., Gaur, P., Rozenblatt-Rosen, O., Zhang, F., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01356-x · Cited by 142
Self-citationGlobal quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease
Ping, L., Kundinger, S. R., Duong, D. M., Yin, L., Gearing, M., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2020) · Scientific Data · doi:10.1038/s41597-020-00650-8 · Cited by 127
Predicting future rates of tau accumulation on PET
Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Botha, H., Graff-Radford, J., Jones, D. T., Ferman, T. J., et al. (2020) · Brain · doi:10.1093/brain/awaa248 · Cited by 117
Tau deposition is associated with functional isolation of the hippocampus in aging
Harrison, T. M., Maaß, A., Adams, J. N., Du, R., Baker, S. L., & Jagust, W. J. (2019) · Nature Communications · doi:10.1038/s41467-019-12921-z · Cited by 113
Hammond, T. C., Xing, X., Wang, C., Ma, D., Nho, K. T., Crane, P. K., Elahi, F. M., Ziegler, D. A., Liang, G., Cheng, Q. S., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1079-x · Cited by 115
Guo, T., Korman, D., Baker, S. L., Landau, S. M., & Jagust, W. J. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.029 · Cited by 103
Amyloid duration is associated with preclinical cognitive decline and tau PET
Koscik, R. L., Betthauser, T. J., Jonaitis, E. M., Allison, S. L., Clark, L. R., Hermann, B. P., Cody, K. A., Engle, J. W., Barnhart, T. E., Stone, C. K., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12007 · Cited by 103
O’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00742-y · Cited by 107
Ossenkoppele, R., Salvadó, G., Janelidze, S., Binette, A. P., Bali, D., Karlsson, L., Palmqvist, S., Mattsson, N., Stomrud, E., Therriault, J., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00835-z · Cited by 144
Local Sleep and Alzheimer’s Disease Pathophysiology
Mander, B. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.525970 · Cited by 97
Social Engagement and Amyloid-β-Related Cognitive Decline in Cognitively Normal Older Adults
Biddle, K. D., Uquillas, F. D., Jacobs, H. I. L., Zide, B. S., Kirn, D. R., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Donovan, N. J. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.05.005 · Cited by 95
Self-citationBuckley, R. F., Mormino, E. C., Chhatwal, J. P., Schultz, A. P., Rabin, J. S., Rentz, D. M., Acar, D., Properzi, M. J., Dumurgier, J., Jacobs, H. I. L., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.019 · Cited by 89
Self-citationYoung, C. B., Winer, J. R., Younes, K., Cody, K. A., Betthauser, T. J., Johnson, S. C., Schultz, A., Sperling, R. A., Greicius, M. D., Cobos, I., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0676 · Cited by 79
Self-citationENGAGE and EMERGE: Truth and consequences?
Kuller, L. H., & López, O. L. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12286 · Cited by 90
Synaptic dysfunction in early phases of Alzheimer's Disease
Pelucchi, S., Gardoni, F., Luca, M. D., & Marcello, E. E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00022-9 · Cited by 95
Boccalini, C., Ribaldi, F., Hristovska, I., Arnone, A., Peretti, D. E., Mu, L., Scheffler, M., Perani, D., Frisoni, G. B., & Garibotto, V. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13355 · Cited by 82
Ullah, R., Park, T. J., Huang, X., & Kim, M. O. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101451 · Cited by 78
Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults
Rentz, D. M., Papp, K. V., Mayblyum, D. V., Sanchez, J. S., Klein, H., Souillard‐Mandar, W., Sperling, R. A., & Johnson, K. A. (2021) · Neurology · doi:10.1212/wnl.0000000000011697 · Cited by 79
Self-citationAnti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs
Lozupone, M., Solfrizzi, V., D’Urso, F., Di Gioia, I., Sardone, R., Dibello, V., Stallone, R., Liguori, A., Ciritella, C., Daniele, A., et al. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1808621 · Cited by 77
Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer’s disease
Cody, K. A., Langhough, R. E., Zammit, M. D., Clark, L. R., Chin, N. A., Christian, B. T., Betthauser, T. J., & Johnson, S. C. (2024) · Brain · doi:10.1093/brain/awae116 · Cited by 71
Chhatwal, J. P., Schultz, A. P., Dang, Y., Ostaszewski, B., Liu, L., Yang, H.-S., Johnson, K. A., Sperling, R. A., & Selkoe, D. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19543-w · Cited by 60
Self-citationKim, B., Elzinga, S. E., Henn, R. E., McGinley, L. M., & Feldman, E. L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104541 · Cited by 71
Tau pathology in cognitively normal older adults
Ziontz, J., Bilgel, M., Shafer, A. T., Moghekar, A., Elkins, W., Helphrey, J. H., Gómez, G., June, D., McDonald, M. A., Dannals, R. F., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.07.007 · Cited by 67
Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases
Mormino, E. C., Toueg, T. N., Azevedo, E. C., Castillo, J. B., Guo, W., Nadiadwala, A., Corso, N. K., Hall, J. N., Fan, A. P., Trelle, A. N., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04923-7 · Cited by 67
Self-citationThe complex pathway between amyloid β and cognition: implications for therapy
Jagust, W. J., Teunissen, C. E., & DeCarli, C. S. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00128-x · Cited by 69
Sanchez, J. S., Hanseeuw, B. J., Lopera, F., Sperling, R. A., Baena, A., Bocanegra, Y., Aguillon, D., Guzmán-Vélez, E., Pardilla-Delgado, E., Ramirez-Gomez, L., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00765-5 · Cited by 58
Self-citationTowards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease
Ossenkoppele, R., & Hansson, O. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12356 · Cited by 62
Knopman, D. S., Lundt, E. S., Therneau, T. M., Albertson, S. M., Gunter, J. L., Senjem, M. L., Schwarz, C. G., Mielke, M. M., Machulda, M. M., Boeve, B. F., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.3921 · Cited by 61
Normal Pressure Hydrocephalus Associated with Alzheimer's Disease
Müller‐Schmitz, K., Krasavina‐Loka, N., Yardimci, T., Lipka, T., Kolman, A. G. J., Robbers, S., Menge, T., Kujovic, M., & Seitz, R. J. (2020) · Annals of Neurology · doi:10.1002/ana.25847 · Cited by 61
AI-driven fusion of multimodal data for Alzheimer’s disease biomarker assessment
Jasodanand, V. H., Kowshik, S. S., Puducheri, S., Romano, M. F., Xu, L., Au, R., & Kolachalama, V. B. (2025) · Nature Communications · doi:10.1038/s41467-025-62590-4 · Cited by 76
Tau‐PET is superior to phospho‐tau when predicting cognitive decline in symptomatic AD patients
Smith, R., Cullen, N. C., Pichet Binette, A., Leuzy, A., Blennow, K., Zetterberg, H., Klein, G., Borroni, E., Ossenkoppele, R., Janelidze, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12875 · Cited by 60
True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretation
Chen, K. T., Toueg, T. N., Koran, M. E. I., Davidzon, G., Zeineh, M., Holley, D., Gandhi, H., Halbert, K., Boumis, A., Kennedy, G., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05151-9 · Cited by 60
Self-citationRegional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults
Chen, X., Cassady, K. E., Adams, J. N., Harrison, T. M., Baker, S. L., & Jagust, W. J. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2111-20.2020 · Cited by 61
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis
Bocancea, D. I., Svenningsson, A. L., van Loenhoud, A. C., Groot, C., Barkhof, F., Strandberg, O. T., Smith, R. A., Initiative, A. D. N., Weiner, M. W., Aisen, P., et al. (2023) · Brain · doi:10.1093/brain/awad100 · Cited by 59
Self-citationLiu, W., Li, J., Yang, M., Ke, X., Dai, Y., Lin, H., Wang, S., Chen, L., & Tao, J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00994-w · Cited by 56
Lu, M., Pontecorvo, M. J., Devous, M. D., Arora, A. K., Galante, N., McGeehan, A., Devadanam, C., Salloway, S. P., Doraiswamy, P. M., Curtis, C., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.5505 · Cited by 56
Self-citationWiner, J. R., Morehouse, A. B., Fenton, L. E., Harrison, T. M., Ayangma, L., Reed, M. E., Kumar, S., Baker, S. L., Jagust, W. J., & Walker, M. P. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0353-21.2021 · Cited by 59
Montal, V., Diez, I., Kim, C.-M., Orwig, W., Bueichekú, E., Gutiérrez-Zúñiga, R., Bejanin, A., Pegueroles, J., Dols-Icardo, O., Vannini, P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn7273 · Cited by 52
Self-citationAlexander, C., Parsaee, A., & Vasefi, M. (2023) · Biology · doi:10.3390/biology12111453 · Cited by 52
Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning
Chen, K. T., Schürer, M., Ouyang, J., Koran, M. E. I., Davidzon, G., Mormino, E. C., Tiepolt, S., Hoffmann, K., Sabri, O., Zaharchuk, G., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04897-6 · Cited by 48
Self-citationTime between milestone events in the Alzheimer's disease amyloid cascade
Insel, P. S., Donohue, M., Berron, D., Hansson, O., & Mattsson, N. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117676 · Cited by 50
Advances in Brain Amyloid Imaging
Krishnadas, N., Villemagne, V. L., Doré, V., & Rowe, C. C. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.005 · Cited by 48
Rodriguez‐Vieitez, E., Montal, V., Sepulcre, J., Lois, C., Hanseeuw, B. J., Vilaplana, E., Schultz, A. P., Properzi, M. J., Scott, M. R., Amariglio, R. E., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01290-z · Cited by 49
Self-citationSex differences in off-target binding using tau positron emission tomography
Smith, R. A., Strandberg, O. T., Leuzy, A., Betthauser, T. J., Johnson, S. C., Pereira, J. B., & Hansson, O. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102708 · Cited by 46
Slater, C. L., & Wang, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.397 · Cited by 47
Das, S. R., Xie, L., Wisse, L. E. M., Vergnet, N., Ittyerah, R., Cui, S., Yushkevich, P. A., Wolk, D. A., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.05.009 · Cited by 47
Neuroimaging of Alzheimer’s disease: focus on amyloid and tau PET
Matsuda, H., Shigemoto, Y., & Sato, N. (2019) · Japanese Journal of Radiology · doi:10.1007/s11604-019-00867-7 · Cited by 50
Wolters, E. E., Dodich, A., Boccardi, M., Corre, J., Drzezga, A. E., Hansson, O., Nordberg, A. K., Frisoni, G. B., Garibotto, V., & Ossenkoppele, R. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05118-w · Cited by 48
Scott, M. R., Hampton, O. L., Buckley, R. F., Chhatwal, J. P., Hanseeuw, B. J., Jacobs, H. I. L., Properzi, M. J., Sanchez, J. S., Johnson, K. A., Sperling, R. A., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116991 · Cited by 46
Self-citationWolters, E. E., Ossenkoppele, R., Verfaillie, S. C. J., Coomans, E. M., Timmers, T., Visser, D., Tuncel, H., Golla, S. S. V., Windhorst, A. D., Boellaard, R., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04758-2 · Cited by 45
Speech pause distribution as an early marker for Alzheimer’s disease
Pastoriza-Domínguez, P., Torre, I. G., Diéguez-Vide, F., Gómez‐Ruiz, I., Geladó, S., López, J. B., Ávila, A., Matías‐Guiu, J. A., Pytel, V., & Hernández-Fernändez, A. (2021) · Speech Communication · doi:10.1016/j.specom.2021.11.009 · Cited by 53
Schwarz, C. G., Therneau, T. M., Weigand, S. D., Gunter, J. L., Lowe, V. J., Przybelski, S. A., Senjem, M. L., Botha, H., Vemuri, P., Kantarci, K., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118259 · Cited by 42
Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults
Vogt, N. M., Hunt, J. F. V., Adluru, N., Ma, Y., Hulle, C. A. V., Dean, D., Kecskemeti, S., Chin, N. A., Carlsson, C. M., Asthana, S., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12364 · Cited by 42
Hampton, O. L., Buckley, R. F., Manning, L. K., Scott, M. R., Properzi, M. J., Peña-Gómez, C., Jacobs, H. I. L., Chhatwal, J. P., Johnson, K. A., Sperling, R. A., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102407 · Cited by 44
Self-citationGroot, C., Doré, V., Robertson, J. S., Burnham, S. C., Savage, G. R., Ossenkoppele, R., Rowe, C. C., & Villemagne, V. L. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.017 · Cited by 41
Tau positron emission tomography in preclinical Alzheimer’s disease
Insel, P. S., Young, C. B., Aisen, P. S. S., Johnson, K. A., Sperling, R. A., Mormino, E. C., & Donohue, M. (2022) · Brain · doi:10.1093/brain/awac299 · Cited by 41
Self-citationTesting the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease
Levin, J., Vöglein, J., Quiroz, Y. T., Bateman, R. J., Ghisays, V., Lopera, F., McDade, E., Reiman, E., Tariot, P. N., & Morris, J. C. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12624 · Cited by 40
Self-citationWhite matter lesions may be an early marker for age-related cognitive decline
Morrison, C., Dadar, M., Villeneuve, S., Collins, D. L., & Initiative, A. D. N. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103096 · Cited by 40
Multi-cellular communities are perturbed in the aging human brain and Alzheimer’s disease
Cain, A., Taga, M., McCabe, C., Green, G., Hekselman, I., White, C. C., Lee, D. I., Gaur, P., Rozenblatt-Rosen, O., Zhang, F., et al. (2020) · doi:10.1101/2020.12.22.424084 · Cited by 143
Self-citationArias, J. F., Brum, W. S., Salvadó, G., Therriault, J., Servaes, S., Wang, Y., Aumont, É., Rahmouni, N., Macedo, A. C., Quispialaya, K. M., et al. (2025) · Brain · doi:10.1093/brain/awaf033 · Cited by 41
Neuromodulation by nanozymes and ultrasound during Alzheimer’s disease management
Karthika, V., Sridharan, B., Nam, J. W., Kim, D., & Lim, H. G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02406-7 · Cited by 40
New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
Penke, B., Szűcs, M., & Bogár, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065383 · Cited by 39
Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions
Rowley, P. A., Samsonov, A. A., Betthauser, T. J., Pirasteh, A., Johnson, S. C., & Eisenmenger, L. B. (2020) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2020.08.011 · Cited by 40
Barthélemy, N. R., Toth, B., Manser, P. T., Sanabria-Bohórquez, S., Teng, E., Keeley, M., Bateman, R. J., Weimer, R. M., & Wildsmith, K. R. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210677 · Cited by 34
Infection and inflammation: New perspectives on Alzheimer's disease
Whitson, H. E., Colton, C. A., Khoury, J. B. E., Gate, D., Goate, A., Heneka, M. T., Kaddurah‐Daouk, R., Klein, R. S., Shinohara, M. L., Sisodia, S. S., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100462 · Cited by 34
Self-citationKrance, S. H., Cogo‐Moreira, H., Rabin, J. S., Black, S. E., & Swardfager, W. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1056-19.2019 · Cited by 36
Self-citationIndividuals with Alzheimer's disease and low tau burden: Characteristics and implications
Landau, S. M., Lee, J., Murphy, A., Ward, T. J., Harrison, T. M., Baker, S. L., DeCarli, C. S., Harvey, D. J., Tosun, D., Weiner, M. W., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13609 · Cited by 35
Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
Han, F., Lee, J., Chen, X., Ziontz, J., Ward, T. J., Landau, S. M., Baker, S. L., Harrison, T. M., Jagust, W. J., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14296 · Cited by 42
Amyloid pathology but notAPOEε4 status is permissive for tau-related hippocampal dysfunction
Düzel, E., Ziegler, G., Berron, D., Maaß, A., Schütze, H., Cárdenas‐Blanco, A., Glanz, W., Metzger, C. D., Dobisch, L., Reuter, M., et al. (2021) · Brain · doi:10.1093/brain/awab405 · Cited by 30
Evaluation of [ 18 F]-JNJ-64326067-AAA tau PET tracer in humans
Baker, S. L., Provost, K., Thomas, W., Whitman, A., Janabi, M., Schmidt, M. E., Timmers, M., Kolb, H. C., Rabinovici, G. D., & Jagust, W. J. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211031035 · Cited by 33
CSF Alzheimer Disease Biomarkers
Greenberg, B., Pettigrew, C. A., Soldan, A., Wang, J., Wang, M., Darrow, J. A., Albert, M., & Moghekar, A. (2022) · Neurology · doi:10.1212/wnl.0000000000200953 · Cited by 32
Teng, E., Manser, P. T., Bohorquez, S. M. S., Wildsmith, K. R., Pickthorn, K., Baker, S. L., Ward, M. E., Kerchner, G. A., & Weimer, R. M. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00937-x · Cited by 34
Speech patterns during memory recall relates to early tau burden across adulthood
Young, C. B., Smith, V., Karjadi, C., Grogan, S., Ang, T. F. A., Insel, P. S., Henderson, V. W., Sumner, M., Poston, K. L., Au, R., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13731 · Cited by 27
Self-citationComparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease
Mayblyum, D. V., Becker, J. A., Jacobs, H. I. L., Buckley, R. F., Schultz, A. P., Sepulcre, J., Sanchez, J. S., Rubinstein, Z. B., Katz, S. R., Moody, K. A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012108 · Cited by 29
Self-citationSmith, G. S., Workman, C. I., Protas, H. D., Su, Y., Savonenko, A. V., Kuwabara, H., Gould, N. F., Kraut, M. A., Joo, J. H., Nandi, A., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01539-9 · Cited by 32
Gabrielli, M., Tozzi, F., Verderio, C., & Origlia, N. (2022) · Cells · doi:10.3390/cells12010063 · Cited by 34
Burnham, S. C., Iaccarino, L., Pontecorvo, M. J., Fleisher, A., Lu, M., Collins, E. C., & Devous, M. D. (2023) · Brain Communications · doi:10.1093/braincomms/fcad305 · Cited by 30
Wang, Z.-T., Shen, X.-N., Ma, Y.-H., Ou, Y.-N., Dong, P. Q., Tan, P. L., & Yu, P. J.-T. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.10.078 · Cited by 28
Seo, E. H., Lim, H. J., Yoon, H., Choi, K. Y., Lee, J. J., Park, J. Y., Choi, S. H., Kim, H., Kim, B. C., & Lee, K. H. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00909-1 · Cited by 26
Age-, sex-, and pathology-related variability in brain structure and cognition
Bachmann, D., Buchmann, A., Studer, S. T., Saake, A., Rauen, K., Zuber, I., Gruber, E., Nitsch, R. M., Höck, C., Gietl, A. F., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02572-6 · Cited by 32
Panza, F., Dibello, V., Sardone, R., Zupo, R., Castellana, F., Leccisotti, I., Moretti, M. C., Altamura, M., Bellomo, A., Daniele, A., et al. (2025) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2025.2463963 · Cited by 28
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
Gouilly, D., Rafiq, M., Nogueira, L., Salabert, A., Payoux, P., Péran, P., & Pariente, J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.006 · Cited by 31
The Effects of Amyloid and Tau on Functional Network Connectivity in Older Populations
Wales, R. M., & Leung, H.-C. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0902 · Cited by 26
Metadata
- Authors
- Sperling, R. A., Mormino, E. C., Schultz, A. P., Betensky, R. A., Papp, K. V., Amariglio, R. E., Hanseeuw, B. J., Buckley, R., Chhatwal, J., Hedden, T., Marshall, G. A., Quiroz, Y. T., Donovan, N. J., Jackson, J., Gatchel, J. R., Rabin, J. S., Jacobs, H., Yang, H., Properzi, M., Kirn, D. R., Rentz, D. M., & Johnson, K. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Corresponding author
- Sperling, Reisa A.
- ORCID
- Sperling, Reisa A.
- Mormino, Elizabeth C.
- Schultz, Aaron P.
- Betensky, Rebecca A.
- Papp, Kathryn V.
- Amariglio, Rebecca E.
- Hanseeuw, Bernard J.
- Buckley, Rachel
- Chhatwal, Jasmeer
- Hedden, Trey
- Marshall, Gad A.
- Quiroz, Yakeel T.
- Donovan, Nancy J.
- Jackson, Jonathan
- Gatchel, Jennifer R.
- Rabin, Jennifer S.
- Jacobs, Heidi
- Yang, Hyun‐Sik
- Properzi, Michael
- Rentz, Dorene M.
- Johnson, Keith A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2019-01-21
- Volume
- 85
- Issue
- 2
- Pages
- 181-193
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC6402593
- OpenAlex
- W2905538154
- Cited by
- 286
- References
- 52
- Citations by year
- 2026: 22 · 2025: 57 · 2024: 42 · 2023: 29 · 2022: 29 · 2021: 52 · 2020: 38 · 2019: 17
- FWCI
- 20.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion, other-oa)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- National Institute on Aging (K24 AG035007, P01AG036694)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- amyloid-beta, tau protein, preclinical Alzheimer's disease, cognitive decline, memory decline, executive function, tau PET, normal aging, older adults, secondary prevention
- MeSH terms
- Aged, Aged, 80 and over, Female, Humans, Longitudinal Studies, Male, Amyloid beta-Peptides, tau Proteins, Positron-Emission Tomography, Cognitive Dysfunction, Memory, Episodic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
